Esperion Therapeutics
Karri Lynn Momyer is a seasoned professional in the field of Chemical Engineering, holding a B.S. from Penn State University and an M.S. from Drexel University. Currently serving as Associate Director of GRA-CMC at Esperion since March 2016, Karri has advanced through various roles, including Sr. Manager and Manager in the same department. Prior experience includes positions at Emergent BioSolutions as an Associate Engineer, Merck as a Process Engineer, and AstraZeneca as a Research Associate. Earlier career experience also comprises a role as Staff Engineer at Cape Environmental Management Inc and as a Research Technician at Bayer.
This person is not in the org chart
This person is not in any teams
Esperion Therapeutics
2 followers
Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at ESPERION is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.